What is Addus HomeCare Corp.'s earnings per share (EPS)?

Addus HomeCare Corp. (ADUS) reported diluted earnings per share of $5.22 for fiscal year 2025. This represents a 23.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Addus HomeCare Corp. (ADUS) Financials

ADUS

Trailing 12 months to June 30, 2026

Revenue $1.5B +15.9% YoY

Net Income $105.3M +26.9% YoY

EPS (Diluted) $5.71 +26.3% YoY

Free Cash Flow $154.8M +65.3% YoY

Market Cap $2.2B as of Oct 13, 2026

Price / Sales 1.5x on $1.5B revenue, trailing 12 months to June 30, 2026

Price / Earnings 20.5x on $105.3M net income, trailing 12 months to June 30, 2026

Price / Book 1.9x on $1.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ADUS SEC filings page.

Addus HomeCare Corp. (ADUS) reported $1.5B in revenue over the twelve months to Jun 30, 2026, up 15.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ADUS FY2025 2026-10-03

FY2025 shows a larger, more profitable home-care operation, but cash generation lagged earnings while leverage fell sharply.

Operating margin widened from 8.9% in FY2024 to 9.7% in FY2025, indicating incremental scale reached profit faster than costs. Cash conversion weakened: net income rose to $95.9M, but free-cash-flow margin fell year over year to 7.3%, so earnings growth did not translate proportionately into cash available after investment.

Leverage declined materially, with debt-to-equity falling from 0.2x in FY2024 to 0.1x in FY2025. Total liabilities fell to $352.0M even as assets reached $1.4B, meaning balance-sheet expansion came with a lower claims burden.

Goodwill dominates the asset base: $996.7M of goodwill sat within $1.4B of total assets. Reported equity growth therefore reflects substantial acquired intangible value, not an equivalent increase in tangible operating resources.

Financial Health Signals

Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Addus HomeCare Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Addus HomeCare Corp. has an operating margin of 9.7%, meaning the company retains $10 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is up from 8.9% the prior year.

Growth

Addus HomeCare Corp.'s revenue surged 23.2% year-over-year to $1.4B, reflecting rapid business expansion. This strong growth earns a score of 77/100.

Leverage

Addus HomeCare Corp. carries a low D/E ratio of 0.11, meaning only $0.11 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 72/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Addus HomeCare Corp.'s current ratio of 1.80 indicates adequate short-term liquidity, earning a score of 53/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Addus HomeCare Corp. has a free cash flow margin of 7.3%, earning a moderate score of 61/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Addus HomeCare Corp. earns a strong 8.8% return on equity (ROE), meaning it generates $9 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 74/100. This is up from 7.6% the prior year.

Altman Z-Score Safe

5.54

Addus HomeCare Corp. scores 5.54, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.2B) relative to total liabilities ($352.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Addus HomeCare Corp. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.16x

For every $1 of reported earnings, Addus HomeCare Corp. generates $1.16 in operating cash flow ($111.5M OCF vs $95.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

10.18x

Addus HomeCare Corp. earns $10.18 in operating income for every $1 of interest expense ($138.6M vs $13.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$377.4M

YoY+8.0%

QoQ+3.8%

5Y CAGR+11.6%

10Y CAGR+14.1%

Addus HomeCare Corp. generated $377.4M in revenue in Q2 2026. This represents an increase of 8.0% from the same quarter a year earlier. Against the prior quarter it is up 3.8%.

EBITDA

$43.1M

YoY+17.0%

QoQ+13.0%

5Y CAGR+15.9%

10Y CAGR+21.5%

Addus HomeCare Corp.'s EBITDA was $43.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.0% from the same quarter a year earlier. Against the prior quarter it is up 13.0%.

Net Income

$27.6M

YoY+25.2%

QoQ+10.1%

5Y CAGR+18.9%

10Y CAGR+26.6%

Addus HomeCare Corp. reported $27.6M in net income in Q2 2026. This represents an increase of 25.2% from the same quarter a year earlier. Against the prior quarter it is up 10.1%.

EPS (Diluted)

$1.49

YoY+24.2%

QoQ+9.6%

5Y CAGR+15.7%

10Y CAGR+20.5%

Addus HomeCare Corp. earned $1.49 per diluted share (EPS) in Q2 2026. This represents an increase of 24.2% from the same quarter a year earlier. Against the prior quarter it is up 9.6%.

Cash & Balance Sheet

Free Cash Flow

$38.7M

YoY+81.8%

QoQ-23.7%

5Y CAGR+22.2%

Addus HomeCare Corp. generated $38.7M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 81.8% from the same quarter a year earlier. Against the prior quarter it is down 23.7%.

Cash & Debt

$99.6M

YoY+9.2%

QoQ-3.4%

5Y CAGR-6.5%

10Y CAGR+28.3%

Addus HomeCare Corp. held $99.6M in cash against $61.6M in long-term debt as of Q2 2026.

Shares Outstanding

19M

YoY+1.5%

QoQ+0.1%

5Y CAGR+3.2%

10Y CAGR+5.0%

Addus HomeCare Corp. had 19M shares outstanding in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

32.2%

YoY-0.4pp

QoQ+0.3pp

5Y change+0.6pp

10Y change+6.8pp

Addus HomeCare Corp.'s gross margin was 32.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin

10.3%

YoY+0.9pp

QoQ+0.9pp

5Y change+2.5pp

10Y change+6.0pp

Addus HomeCare Corp.'s operating margin was 10.3% in Q2 2026, reflecting core business profitability. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Net Margin

7.3%

YoY+1.0pp

QoQ+0.4pp

5Y change+2.0pp

10Y change+4.7pp

Addus HomeCare Corp.'s net profit margin was 7.3% in Q2 2026, showing the share of revenue converted to profit. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.

Return on Equity

2.4%

YoY+0.2pp

QoQ+0.2pp

5Y change+0.3pp

10Y change+0.6pp

Addus HomeCare Corp.'s ROE was 2.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Capital Allocation

Capital Expenditures

$1.3M

YoY+6.9%

QoQ-21.7%

5Y CAGR+10.1%

10Y CAGR+13.8%

Addus HomeCare Corp. invested $1.3M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 6.9% from the same quarter a year earlier. Against the prior quarter it is down 21.7%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

ADUS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ADUS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.5B	$1.4B+23.2%	$1.2B+9.1%	$1.1B+11.3%	$951.1M+10.0%	$864.5M+13.0%	$764.8M+17.9%	$648.8M+25.6%	$516.6M+21.3%	$426.0M+6.3%	$400.9M+19.0%	$336.8M+7.6%	$312.9M+17.7%	$265.9M+8.9%	$244.3M+6.2%	$230.1M
Cost of Revenue	$998.7M	$960.7M+23.2%	$779.6M+8.5%	$718.8M+10.3%	$651.4M+9.5%	$594.7M+10.4%	$538.5M+14.7%	$469.6M+23.6%	$379.8M+22.5%	$310.1M+5.3%	$294.6M	N/A	N/A	N/A	N/A	N/A
Gross Profit	$477.8M	$461.9M+23.2%	$375.0M+10.3%	$339.9M+13.4%	$299.7M+11.1%	$269.8M+19.3%	$226.2M+26.2%	$179.2M+31.0%	$136.8M+18.1%	$115.9M+9.0%	$106.3M+16.4%	$91.3M+9.1%	$83.7M+23.6%	$67.7M+5.8%	$64.1M+4.2%	$61.5M
SG&A Expenses	$312.8M	$306.8M+18.6%	$258.8M+10.2%	$234.8M+8.2%	$216.9M+14.5%	$189.4M+11.6%	$169.7M+26.7%	$133.9M+27.1%	$105.3M+37.0%	$76.9M+0.1%	$76.8M+16.2%	$66.1M+7.0%	$61.8M+23.4%	$50.1M+8.1%	$46.4M+1.1%	$45.9M
Operating Income	$148.2M	$138.6M+35.0%	$102.7M+12.9%	$91.0M+32.3%	$68.7M+4.2%	$65.9M+48.1%	$44.5M+28.1%	$34.8M+52.2%	$22.8M-9.6%	$25.3M+63.2%	$15.5M-3.4%	$16.0M-11.3%	$18.1M+16.9%	$15.5M-1.3%	$15.7M+21.3%	$12.9M
EBITDA	N/A	$155.0M+33.4%	$116.2M+10.6%	$105.1M+26.9%	$82.8M+2.9%	$80.4M+42.2%	$56.6M+24.8%	$45.3M+44.0%	$31.5M-1.4%	$31.9M+44.3%	$22.1M+6.7%	$20.7M-5.3%	$21.9M+24.3%	$17.6M-3.2%	$18.2M+13.2%	$16.1M
Interest Expense	$9.9M	$13.6M+76.0%	$7.7M-30.4%	$11.1M+24.7%	$8.9M+53.4%	$5.8M+82.1%	$3.2M+2.7%	$3.1M-38.1%	$5.0M+12.2%	$4.5M+91.8%	$2.3M+196.7%	$786K+12.6%	$698K+3.6%	$674K-60.9%	$1.7M-31.7%	$2.5M
Income Tax	$35.4M	$31.5M+22.4%	$25.8M+36.9%	$18.8M+33.0%	$14.1M-7.4%	$15.3M+73.4%	$8.8M+19.7%	$7.4M+79.7%	$4.1M-55.8%	$9.3M+125.9%	$4.1M+4.2%	$3.9M-27.6%	$5.4M+42.4%	$3.8M-20.7%	$4.8M+13.3%	$4.2M
Net Income	$105.3M	$95.9M+30.3%	$73.6M+17.7%	$62.5M+35.8%	$46.0M+2.0%	$45.1M+36.2%	$33.1M+31.3%	$25.2M+53.6%	$16.4M+37.5%	$12.0M-1.7%	$12.2M+4.6%	$11.6M-5.1%	$12.2M-36.1%	$19.1M+150.8%	$7.6M+485.4%	-$2.0M
EPS (Basic)	N/A	$5.31+22.6%	$4.33+10.7%	$3.91+34.8%	$2.90+1.0%	$2.87+35.4%	$2.12+15.8%	$1.83+34.6%	$1.36+30.8%	$1.04-2.8%	$1.07+0.9%	$1.06-5.4%	$1.12-36.7%	$1.77+149.3%	$0.71+494.4%	-$0.18
EPS (Diluted)	$5.71	$5.22+23.4%	$4.23+10.4%	$3.83+34.9%	$2.84+1.1%	$2.81+35.1%	$2.08+17.5%	$1.77+33.1%	$1.33+29.1%	$1.03-3.7%	$1.07+2.9%	$1.04-5.5%	$1.10-36.4%	$1.73+143.7%	$0.71+494.4%	-$0.18
Diluted Shares (Avg)	N/A	18M+5.8%	17M+6.6%	16M+0.8%	16M+0.7%	16M+0.7%	16M+12.0%	14M+15.1%	12M+6.5%	12M+2.4%	11M+1.4%	11M+0.7%	11M+0.4%	11M+2.7%	11M+0.3%	11M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$377.4M+8.0%	$363.6M+7.7%	$373.1M+25.6%	$362.3M+25.0%	$349.4M+21.8%	$337.7M+20.3%	$297.1M+7.5%	$289.8M+7.0%
Cost of Revenue	$255.9M+8.6%	$247.7M+7.7%	$249.5M+27.5%	$245.6M+24.3%	$235.6M+21.6%	$230.0M+19.5%	$195.7M+6.4%	$197.6M+7.4%
Gross Profit	$121.6M+6.7%	$115.9M+7.6%	$123.6M+21.8%	$116.7M+26.6%	$113.9M+22.2%	$107.7M+22.1%	$101.5M+9.8%	$92.2M+6.3%
SG&A Expenses	$78.5M+1.8%	$77.8M+6.2%	$77.2M+8.2%	$79.4M+26.4%	$77.1M+21.2%	$73.2M+19.9%	$71.4M+17.4%	$62.8M+4.2%
Operating Income	$38.9M+18.4%	$34.1M+11.7%	$42.3M+57.1%	$32.9M+26.9%	$32.9M+25.6%	$30.5M+29.1%	$26.9M-3.8%	$26.0M+13.6%
EBITDA	$43.1M+17.0%	$38.1M+10.6%	$46.4M+54.1%	$37.3M+27.0%	$36.8M+24.4%	$34.5M+27.1%	$30.1M-4.8%	$29.4M+11.1%
Interest Expense	$1.7M-51.1%	$2.2M-46.5%	$2.7M+19.2%	$3.3M+483.4%	$3.5M+66.7%	$4.0M+45.7%	$2.3M-26.6%	$573K-82.1%
Income Tax	$10.2M+28.9%	$7.4M+27.6%	$10.4M+55.0%	$7.5M+5.3%	$7.9M+22.1%	$5.8M+5.3%	$6.7M+15.8%	$7.1M+48.2%
Net Income	$27.6M+25.2%	$25.1M+18.1%	$29.8M+52.5%	$22.8M+13.3%	$22.1M+22.0%	$21.2M+34.1%	$19.5M-0.3%	$20.2M+30.8%
EPS (Basic)	$1.51+23.8%	$1.38+16.9%	$1.64+50.5%	$1.26+11.5%	$1.22+8.9%	$1.18+19.2%	$1.09-10.7%	$1.13+17.7%
EPS (Diluted)	$1.49+24.2%	$1.36+17.2%	$1.62+52.8%	$1.24+12.7%	$1.20+9.1%	$1.16+19.6%	$1.06-11.7%	$1.10+15.8%
Diluted Shares (Avg)	18M+0.8%	18M+1.0%	N/A	18M+0.7%	18M+11.1%	18M+11.8%	N/A	18M+12.1%

Not reported in any period shown, so not listed: R&D Expenses.

ADUS Balance Sheet

ADUS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.4B+1.7%	$1.4B+37.9%	$1.0B+9.2%	$938.0M-1.0%	$947.6M+6.2%	$892.6M+40.2%	$636.7M+82.9%	$348.1M+28.1%	$271.7M+18.2%	$229.9M+23.7%	$185.8M+2.8%	$180.8M+10.3%	$163.9M+9.4%	$149.9M-3.1%	$154.7M
Current Assets	$269.5M+3.5%	$260.4M+30.2%	$200.0M-10.2%	$222.8M-31.3%	$324.3M+12.7%	$287.7M+6.8%	$269.4M+53.0%	$176.0M+13.1%	$155.7M+18.8%	$131.0M+39.5%	$93.9M-3.5%	$97.4M+6.4%	$91.5M+4.1%	$87.8M-1.4%	$89.1M
Cash & Equivalents	$81.6M-17.5%	$98.9M+52.7%	$64.8M-19.0%	$80.0M-52.7%	$168.9M+16.4%	$145.1M+29.9%	$111.7M+58.7%	$70.4M+31.0%	$53.8M+570.8%	$8.0M+95.2%	$4.1M-69.3%	$13.4M-14.1%	$15.6M+796.1%	$1.7M-14.0%	$2.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$151.7M+23.4%	$122.9M+6.4%	$115.5M-8.0%	$125.5M-8.4%	$137.0M+3.2%	$132.7M-11.4%	$149.7M+52.2%	$98.3M+5.1%	$93.5M-20.1%	$117.0M+37.7%	$85.0M+24.3%	$68.3M+11.4%	$61.4M-14.0%	$71.3M-1.5%	$72.4M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$996.7M+2.7%	$970.6M+46.4%	$663.0M+13.8%	$582.8M+15.6%	$504.4M+7.5%	$469.1M+70.3%	$275.4M+103.3%	$135.4M+49.9%	$90.3M+24.3%	$72.7M+7.5%	$67.6M+5.3%	$64.2M+7.0%	$60.0M+18.8%	$50.5M-0.3%	$50.7M
Total Liabilities	$352.0M-20.4%	$442.1M+39.2%	$317.7M+4.4%	$304.5M-18.4%	$373.2M-0.2%	$373.9M+132.0%	$161.2M+102.4%	$79.6M-16.5%	$95.4M+32.3%	$72.1M+63.6%	$44.1M-16.6%	$52.8M+5.5%	$50.1M-9.7%	$55.4M-18.8%	$68.3M
Current Liabilities	$149.5M-4.1%	$155.9M+7.4%	$145.1M+10.7%	$131.1M+11.4%	$117.7M-18.2%	$143.9M+64.4%	$87.5M+42.3%	$61.5M+11.7%	$55.1M+11.0%	$49.6M+17.6%	$42.2M-2.4%	$43.2M-5.1%	$45.5M+16.2%	$39.2M-9.5%	$43.3M
Non-Current Liabilities	$202.5M-29.3%	$286.3M+65.8%	$172.6M-0.4%	$173.3M-32.2%	$255.6M+11.1%	$230.0M+212.4%	$73.6M+306.8%	$18.1M-55.1%	$40.3M+79.3%	$22.5M+158.5%	$8.7M-9.8%	$9.6M+112.3%	$4.5M-72.1%	$16.3M-34.9%	$25.0M
Long-Term Debt	$121.0M-44.6%	$218.4M+76.0%	$124.1M-5.8%	$131.8M-40.4%	$220.9M+13.9%	$193.9M+227.7%	$59.2M+243.5%	$17.2M-56.8%	$39.9M+77.3%	$22.5M+1094.6%	$1.9M	N/A	N/A	$16.3M-34.9%	$25.0M
Total Equity	$1.1B+11.8%	$970.5M+37.3%	$706.7M+11.5%	$633.5M+10.3%	$574.3M+10.7%	$518.7M+9.1%	$475.6M+77.1%	$268.5M+57.6%	$170.3M+10.1%	$154.7M+9.2%	$141.6M+11.7%	$126.8M+11.4%	$113.9M+20.6%	$94.4M+9.2%	$86.4M
Retained Earnings	$472.3M+25.5%	$376.4M+24.3%	$302.8M+26.0%	$240.3M+23.7%	$194.3M+30.3%	$149.2M+28.6%	$116.0M+27.8%	$90.8M+13.0%	$80.3M+22.7%	$65.5M+19.9%	$54.6M+27.0%	$43.0M+39.8%	$30.8M+164.6%	$11.6M+191.2%	$4.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.5B+3.4%	$1.4B+2.0%	$1.4B+1.7%	$1.4B+23.4%	$1.4B+26.2%	$1.4B+38.8%	$1.4B+37.9%	$1.2B+11.3%
Current Assets	$284.1M+8.0%	$272.9M+5.8%	$269.5M+3.5%	$260.7M-21.7%	$263.0M-10.8%	$257.8M+34.4%	$260.4M+30.2%	$332.8M+57.5%
Cash & Equivalents	$99.6M+9.2%	$103.1M+6.3%	$81.6M-17.5%	$101.9M-54.3%	$91.2M-47.4%	$97.0M+26.4%	$98.9M+52.7%	$222.9M+179.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$145.1M+3.6%	$144.8M+7.6%	$151.7M+23.4%	$134.1M+38.8%	$140.1M+28.3%	$134.6M+28.5%	$122.9M+6.4%	$96.6M-20.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.0B+3.9%	$996.7M+2.5%	$996.7M+2.7%	$988.6M+49.0%	$969.8M+46.1%	$972.3M+46.6%	$970.6M+46.4%	$663.6M+0.1%
Total Liabilities	$308.3M-20.3%	$319.5M-22.5%	$352.0M-20.4%	$373.0M+81.7%	$387.1M+98.6%	$412.2M+42.7%	$442.1M+39.2%	$205.3M-41.6%
Current Liabilities	$168.1M+11.1%	$149.5M+1.0%	$149.5M-4.1%	$156.8M-0.6%	$151.4M+2.6%	$147.9M+4.5%	$155.9M+7.4%	$157.8M+13.0%
Non-Current Liabilities	$140.2M-40.5%	$170.1M-35.6%	$202.5M-29.3%	$216.2M+355.6%	$235.7M+397.6%	$264.3M+79.4%	$286.3M+65.8%	$47.4M-77.6%
Long-Term Debt	$61.6M-63.6%	$91.3M-54.1%	$121.0M-44.6%	$150.6M	$169.1M	$198.7M+100.0%	$218.4M+76.0%	N/A
Total Equity	$1.1B+12.4%	$1.1B+12.1%	$1.1B+11.8%	$1.0B+10.8%	$1.0B+10.9%	$995.4M+37.3%	$970.5M+37.3%	$947.6M+38.5%
Retained Earnings	$525.0M+25.1%	$497.4M+25.1%	$472.3M+25.5%	$442.6M+24.0%	$419.7M+24.6%	$397.7M+24.8%	$376.4M+24.3%	$356.9M+26.0%

Not reported in any period shown, so not listed: Inventory.

ADUS Cash Flow Statement

ADUS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$162.4M	$111.5M-4.2%	$116.4M+3.7%	$112.2M+6.8%	$105.1M+166.2%	$39.5M-63.9%	$109.4M+810.3%	$12.0M-63.8%	$33.2M-37.1%	$52.8M+7202.4%	-$743K-118.1%	$4.1M-41.6%	$7.0M-74.3%	$27.4M+77.8%	$15.4M-3.4%	$15.9M
Depreciation & Amortization	N/A	$16.4M+21.3%	$13.5M-4.2%	$14.1M+0.5%	$14.1M-3.0%	$14.5M+20.3%	$12.1M+14.0%	$10.6M+22.4%	$8.6M+29.7%	$6.7M+0.2%	$6.6M+40.9%	$4.7M+23.2%	$3.8M+77.3%	$2.2M-15.1%	$2.5M-19.7%	$3.2M
Stock-Based Compensation	N/A	$16.4M+47.1%	$11.2M+8.2%	$10.3M-2.9%	$10.6M+12.6%	$9.4M+57.1%	$6.0M+4.1%	$5.8M+40.3%	$4.1M+61.0%	$2.6M+138.1%	$1.1M-31.8%	$1.6M+90.2%	$827K+60.6%	$515K+51.0%	$341K+3.0%	$331K
Capital Expenditures	$7.6M	$7.7M+27.6%	$6.0M-36.0%	$9.5M+13.9%	$8.3M+78.7%	$4.6M-32.0%	$6.8M+47.8%	$4.6M-13.6%	$5.3M+47.9%	$3.6M+111.2%	$1.7M-22.6%	$2.2M-58.0%	$5.3M+494.6%	$887K-20.4%	$1.1M+102.2%	$551K
Free Cash Flow	$154.8M	$103.8M-6.0%	$110.4M+7.4%	$102.8M+6.2%	$96.8M+177.8%	$34.8M-66.0%	$102.6M+1286.6%	$7.4M-73.4%	$27.9M-43.3%	$49.2M+2102.2%	-$2.5M-229.7%	$1.9M+7.9%	$1.8M-93.4%	$26.5M+85.5%	$14.3M-7.2%	$15.4M
Investing Cash Flow	-$48.0M	-$32.5M+90.8%	-$354.6M-197.4%	-$119.2M-11.9%	-$106.6M-153.7%	-$42.0M+80.4%	-$214.2M-13.5%	-$188.7M-178.4%	-$67.8M-179.3%	-$24.3M-11.6%	-$21.7M-102.7%	-$10.7M	N/A	$2.9M+567.4%	-$619K+41.1%	-$1.1M
Financing Cash Flow	-$106.0M	-$96.3M-135.4%	$272.3M+3428.4%	-$8.2M+90.6%	-$87.5M-432.0%	$26.3M-80.9%	$138.2M-36.6%	$218.0M+325.4%	$51.2M+197.2%	$17.2M-34.7%	$26.4M+1099.2%	-$2.6M	N/A	-$16.5M-9.2%	-$15.1M-10.1%	-$13.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$40.0M+77.6%	$52.4M+176.3%	$18.8M+80.1%	$51.3M+5.6%	$22.5M+19.8%	$18.9M-51.0%	$10.4M-65.3%	$48.5M+122.7%
Depreciation & Amortization	$4.1M+5.4%	$4.0M+2.2%	$4.1M+29.1%	$4.4M+27.9%	$3.9M+15.1%	$3.9M+13.7%	$3.2M-12.6%	$3.4M-4.8%
Stock-Based Compensation	N/A	$5.0M+57.7%	N/A	N/A	N/A	$3.2M+21.0%	N/A	N/A
Capital Expenditures	$1.3M+6.9%	$1.7M-9.1%	$2.7M+56.9%	$1.9M-0.6%	$1.3M+17.0%	$1.9M+39.5%	$1.7M-68.1%	$1.9M-18.2%
Free Cash Flow	$38.7M+81.8%	$50.7M+196.8%	$16.1M+84.6%	$49.3M+5.9%	$21.3M+19.9%	$17.1M-54.3%	$8.7M-64.7%	$46.6M+139.9%
Investing Cash Flow	-$13.5M-896.8%	-$1.7M-22.8%	-$10.1M+97.2%	-$22.8M-1084.2%	$1.7M-52.2%	-$1.4M+21.3%	-$354.5M-6585.9%	-$1.9M+98.3%
Financing Cash Flow	-$30.0M0.0%	-$29.2M-49.7%	-$29.0M-113.2%	-$17.8M-703.4%	-$30.0M-140.4%	-$19.5M+21.9%	$220.1M+654.4%	$2.9M-96.5%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ADUS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ADUS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	32.5%0.0pp	32.5%+0.4pp	32.1%+0.6pp	31.5%+0.3pp	31.2%+1.6pp	29.6%+2.0pp	27.6%+1.2pp	26.5%-0.7pp	27.2%+0.7pp	26.5%-0.6pp	27.1%+0.4pp	26.8%+1.3pp	25.5%-0.8pp	26.2%-0.5pp	26.7%
Operating Margin	9.7%+0.8pp	8.9%+0.3pp	8.6%+1.4pp	7.2%-0.4pp	7.6%+1.8pp	5.8%+0.5pp	5.4%+0.9pp	4.4%-1.5pp	5.9%+2.1pp	3.9%-0.9pp	4.8%-1.0pp	5.8%0.0pp	5.8%-0.6pp	6.4%+0.8pp	5.6%
Net Margin	6.7%+0.4pp	6.4%+0.5pp	5.9%+1.1pp	4.8%-0.4pp	5.2%+0.9pp	4.3%+0.4pp	3.9%+0.7pp	3.2%+0.4pp	2.8%-0.2pp	3.0%-0.4pp	3.5%-0.5pp	3.9%-3.3pp	7.2%+4.1pp	3.1%+4.0pp	-0.9%
Return on Equity	8.8%+1.3pp	7.6%-1.3pp	8.8%+1.6pp	7.3%-0.6pp	7.9%+1.5pp	6.4%+1.1pp	5.3%-0.8pp	6.1%-0.9pp	7.0%-0.8pp	7.9%-0.4pp	8.2%-1.4pp	9.7%-7.2pp	16.8%+8.7pp	8.1%+10.4pp	-2.3%
Return on Assets	6.7%+1.5pp	5.2%-0.9pp	6.1%+1.2pp	4.9%+0.1pp	4.8%+1.1pp	3.7%-0.3pp	4.0%-0.8pp	4.7%+0.3pp	4.4%-0.9pp	5.3%-1.0pp	6.3%-0.5pp	6.8%-4.9pp	11.7%+6.6pp	5.1%+6.4pp	-1.3%
Current Ratio	1.80+0.1x	1.67+0.3x	1.38-0.3x	1.70-1.1x	2.76+0.8x	2.00-1.1x	3.08+0.2x	2.860.0x	2.83+0.2x	2.64+0.4x	2.230.0x	2.25+0.2x	2.01-0.2x	2.24+0.2x	2.06
Debt-to-Equity	0.11-0.1x	0.230.0x	0.180.0x	0.21-0.2x	0.380.0x	0.37+0.2x	0.12+0.1x	0.06-0.2x	0.23+0.1x	0.15+0.1x	0.01-0.4x	0.420.0x	0.44+0.3x	0.17-0.1x	0.29
Asset Turnover	0.99+0.2x	0.82-0.2x	1.030.0x	1.01+0.1x	0.91+0.1x	0.86-0.2x	1.02-0.5x	1.48-0.1x	1.57-0.2x	1.74-0.1x	1.81+0.1x	1.73+0.1x	1.620.0x	1.63+0.1x	1.49
FCF Margin	7.3%-2.3pp	9.6%-0.2pp	9.7%-0.5pp	10.2%+6.2pp	4.0%-9.4pp	13.4%+12.3pp	1.1%-4.3pp	5.4%-6.2pp	11.5%+12.2pp	-0.6%-1.2pp	0.6%0.0pp	0.6%-9.4pp	10.0%+4.1pp	5.9%-0.8pp	6.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	32.2%-0.4pp	31.9%0.0pp	33.1%-1.0pp	32.2%+0.4pp	32.6%+0.1pp	31.9%+0.5pp	34.2%+0.7pp	31.8%-0.2pp
Operating Margin	10.3%+0.9pp	9.4%+0.3pp	11.3%+2.3pp	9.1%+0.1pp	9.4%+0.3pp	9.0%+0.6pp	9.1%-1.1pp	9.0%+0.5pp
Net Margin	7.3%+1.0pp	6.9%+0.6pp	8.0%+1.4pp	6.3%-0.6pp	6.3%0.0pp	6.3%+0.6pp	6.6%-0.5pp	7.0%+1.3pp
Return on Equity	2.4%+0.2pp	2.3%+0.1pp	2.7%+0.7pp	2.2%+0.1pp	2.2%+0.2pp	2.1%-0.1pp	2.0%-0.8pp	2.1%-0.1pp
Return on Assets	1.9%+0.3pp	1.8%+0.2pp	2.1%+0.7pp	1.6%-0.1pp	1.6%-0.1pp	1.5%0.0pp	1.4%-0.5pp	1.8%+0.3pp
Current Ratio	1.690.0x	1.83+0.1x	1.80+0.1x	1.66-0.4x	1.74-0.3x	1.74+0.4x	1.67+0.3x	2.11+0.6x
Debt-to-Equity	0.05-0.1x	0.08-0.1x	0.11-0.1x	0.14-0.1x	0.170.0x	0.20+0.1x	0.230.0x	0.220.0x
Asset Turnover	0.260.0x	0.250.0x	0.260.0x	0.250.0x	0.250.0x	0.240.0x	0.21-0.1x	0.250.0x
FCF Margin	10.3%+4.2pp	13.9%+8.9pp	4.3%+1.4pp	13.6%-2.5pp	6.1%-0.1pp	5.1%-8.3pp	2.9%-6.0pp	16.1%+8.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Addus HomeCare Corp. ADUS	FY2025	$1.4B	$95.9M	6.7%	$2.2B	68/100
Acadia Healthcare Company, Inc. ACHC	FY2025	$3.3B	-$1.1B	-33.3%	$2.8B	25/100
LifeStance Health Group, Inc. LFST	FY2025	$1.4B	$9.7M	0.7%	$4.7B	51/100
Surgery Partners, Inc. SGRY	FY2025	$3.3B	-$77.9M	-2.4%	$1.9B	54/100
Aveanna Healthcare Holdings Inc. AVAH	FY2026	$2.4B	$225K	0.0%	$2.7B	36/100

Where Addus HomeCare Corp. Ranks

Frequently Asked Questions

What is Addus HomeCare Corp.'s annual revenue?

Addus HomeCare Corp. (ADUS) reported $1.4B in total revenue for fiscal year 2025. This represents a 23.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Addus HomeCare Corp.'s revenue growing?

Addus HomeCare Corp. (ADUS) revenue grew by 23.2% year-over-year, from $1.2B to $1.4B in fiscal year 2025.

Is Addus HomeCare Corp. profitable?

Yes, Addus HomeCare Corp. (ADUS) reported a net income of $95.9M in fiscal year 2025, with a net profit margin of 6.7%.

What is Addus HomeCare Corp.'s EBITDA?

Addus HomeCare Corp. (ADUS) had EBITDA of $155.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Addus HomeCare Corp. have?

As of fiscal year 2025, Addus HomeCare Corp. (ADUS) had $81.6M in cash and equivalents against $121.0M in long-term debt.

What is Addus HomeCare Corp.'s gross margin?

Addus HomeCare Corp. (ADUS) had a gross margin of 32.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Addus HomeCare Corp.'s operating margin?

Addus HomeCare Corp. (ADUS) had an operating margin of 9.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Addus HomeCare Corp.'s net profit margin?

Addus HomeCare Corp. (ADUS) had a net profit margin of 6.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Addus HomeCare Corp.'s return on equity (ROE)?

Addus HomeCare Corp. (ADUS) has a return on equity of 8.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Addus HomeCare Corp.'s free cash flow?

Addus HomeCare Corp. (ADUS) generated $103.8M in free cash flow during fiscal year 2025. This represents a -6.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Addus HomeCare Corp.'s operating cash flow?

Addus HomeCare Corp. (ADUS) generated $111.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Addus HomeCare Corp.'s total assets?

Addus HomeCare Corp. (ADUS) had $1.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Addus HomeCare Corp.'s capital expenditures?

Addus HomeCare Corp. (ADUS) invested $7.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Addus HomeCare Corp. have outstanding?

Addus HomeCare Corp. (ADUS) had 19M shares outstanding as of fiscal year 2025.

What is Addus HomeCare Corp.'s current ratio?

Addus HomeCare Corp. (ADUS) had a current ratio of 1.80 as of fiscal year 2025, which is generally considered healthy.

What is Addus HomeCare Corp.'s debt-to-equity ratio?

Addus HomeCare Corp. (ADUS) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Addus HomeCare Corp.'s return on assets (ROA)?

Addus HomeCare Corp. (ADUS) had a return on assets of 6.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Addus HomeCare Corp.'s P/E ratio?

Addus HomeCare Corp. (ADUS) trades at 20.5x earnings, its market capitalization divided by net income of $105.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.2B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Addus HomeCare Corp.'s price-to-sales ratio?

Addus HomeCare Corp. (ADUS) trades at 1.5x sales, its market capitalization divided by revenue of $1.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.2B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Addus HomeCare Corp.'s Altman Z-Score?

Addus HomeCare Corp. (ADUS) has an Altman Z-Score of 5.54, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Addus HomeCare Corp.'s Piotroski F-Score?

Addus HomeCare Corp. (ADUS) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Addus HomeCare Corp.'s earnings high quality?

Addus HomeCare Corp. (ADUS) has an earnings quality ratio of 1.16x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Addus HomeCare Corp. cover its interest payments?

Addus HomeCare Corp. (ADUS) has an interest coverage ratio of 10.18x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Addus HomeCare Corp.?

Addus HomeCare Corp. (ADUS) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.